TS WONDERS 01767.HK 深 滬
已收盤 09-05 16:10:00
0.290
0.000
0.00%
華盛通- 最 高0.290
- 今 開0.285
- 成交量 12.00万股
- 最 低 0.280
- 昨 收 0.290
- 總市值 2.90亿
- 52周最高 0.428
- 市盈率 靜 8.03
- 換手率 0.00%
- 52周最低 0.170
- 委 比 36.33%
- 總股本 10.00亿
- 歷史最高 0.340
- 量 比 0.20
- 振 幅 3.45%
- 歷史最低 0.127
- 每 手 10000
- 風險率 0.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多TS WONDERS(01767.HK)发布中期业绩 期内溢利218.69万新加坡元 同比减少45.67%
TS WONDERS(01767.HK)发布2025年中期业绩，收益3506.79万新加坡元，同比增加6.63%;期内溢利218.69万新加坡元，同比减少45.67%;每股基本盈利0.22分。
08-29 17:46
TS WONDERS(01767)发布中期业绩 期内溢利218.69万新加坡元 同比减少45.67%
TS WONDERS(01767)发布2025年中期业绩，收益3506.79万新...
08-29 17:23
TS WONDERS(01767.HK)发布公告，自2025年6月30日起，林小燕获委任为董事会提名委员会成员
TS WONDERS(01767.HK)发布公告，自2025年6月30日起，林小燕获委任为董事会提名委员会成员。
06-30 17:10
Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV
Journey Medical Corporation announced the airing of a TV segment featuring its FDA-approved Emrosi™ for treating rosacea on "The Balancing Act." Premiering on June 9 and rebroadcasting on June 19, the segment provides expert insights on managing rosacea and highlights Emrosi's unique formulation as the lowest-dose oral minocycline option. Emrosi is available by prescription and offers a favorable safety profile. The National Rosacea Society estim...
06-09 12:30
Mondelēz International Expands Sustainable Futures Portfolio Aiming to Accelerate Scalable Climate and Community Initiatives
Mondelēz International launched new impact-first investments through its Sustainable Futures platform, focusing on regenerative agriculture, inclusive financing, and circular packaging via innovative tech. The company employs a three-pronged approach—direct investments, fund investments, and technical assistance—to scale solutions aligned with its Vision 2030 Sustainability strategy. Key investments include eAgronom for sustainable farming, ZIRO ...
05-29 20:05
